Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain

Lister, J. orcid.org/0000-0002-7166-4758, Stanisic, S., Kaier, K. et al. (3 more authors) (2012) Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain. ClinicoEconomics and Outcomes Research , 4. pp. 299-305. ISSN 1178-6981

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2012 Lister et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
Keywords: France; Germany; Italy; Spain; bevacizumab; chemotherapy; economic model; non-small-cell lung cancer
Dates:
  • Published: 4 October 2012
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 13 Oct 2017 09:36
Last Modified: 13 Oct 2017 09:36
Published Version: https://doi.org/10.2147/CEOR.S34188
Status: Published
Publisher: Dove Medical Press
Refereed: Yes
Identification Number: https://doi.org/10.2147/CEOR.S34188
Related URLs:

Share / Export

Statistics